Advances in Prostate Cancer: Androgen Deprivation Therapy Across the Disease Continuum

Explore expert-guided education on the use of novel therapies for patients with nonmetastatic hormone-sensitive and castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer with a webcast of a live meeting, downloadable slides, a podcast, and a focused commentary.

Daniel W. Lin, MD

Alicia K. Morgans, MD, MPH

David F. Penson, MD, MPH

ClinicalThought

Integrating New Agents and Advances Into Current Prostate Cancer Treatment

View ClinicalThought

In this commentary, 3 prostate cancer experts discuss recent advances in treating patients with prostate cancer, including use of GnRH antagonists and androgen receptor inhibitors and the management of patients with comorbidities.

Daniel W. Lin, MD

Alicia K. Morgans, MD, MPH

David F. Penson, MD, MPH Released: November 2, 2021